Panel discussion on vaccine development to meet U.S. and international needs. Strategies for reducing the disincentives to HIV vaccine development: description of a successful public-private sector international collaboration.
Bronnenkant
L
L
Finishing Enterprises, N. Tonawanda, New York 14120.
D016915:AIDS Vaccines / Q000191:economics / Q000302:isolation & purification*; D017277:Drug Approval; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D007391:International Cooperation; D007435:Intrauterine Devices, Copper / Q000191:economics; D016365:Liability, Legal; D014481:United States
D016915:AIDS Vaccines